JPH10234737A - Metabolic information measuring probe - Google Patents

Metabolic information measuring probe

Info

Publication number
JPH10234737A
JPH10234737A JP9044411A JP4441197A JPH10234737A JP H10234737 A JPH10234737 A JP H10234737A JP 9044411 A JP9044411 A JP 9044411A JP 4441197 A JP4441197 A JP 4441197A JP H10234737 A JPH10234737 A JP H10234737A
Authority
JP
Japan
Prior art keywords
light
probe
irradiation
face
metabolic information
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP9044411A
Other languages
Japanese (ja)
Inventor
Nobuyuki Michiguchi
信行 道口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Corp
Original Assignee
Olympus Optical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Optical Co Ltd filed Critical Olympus Optical Co Ltd
Priority to JP9044411A priority Critical patent/JPH10234737A/en
Publication of JPH10234737A publication Critical patent/JPH10234737A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a metabolic information measuring probe by which the measurement of the metabolic information of the pulsating cardiac muscle of heart can be accurately carried out with good operability. SOLUTION: The metabolic information measuring probe 10 being attachable and detachable to a control unit 1 is made up of a universal code 17 and its end part 18, and is provided with an irradiation fiber 11 for introducing the near infrared rays emitted from an irradiation means 2 of the control unit 1 up to the end part 18, a light-receiving fiber 15, through which the scattered light that has been radiated by the irradiation fiber 11 and has transmitted through the inside of the cardiac muscle is taken in from the end part 18 and is introduced up to the light-receiving means 4 of the control unit 1, and a belt-shaped holding means 19 for holding the end part 18 when it is brought into contact with the cardiac muscle by fitting it to the tip of an operator's finger.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、代謝情報測定用プ
ローブ、より詳しくは、近赤外光を照射して測定対象の
内部を透過した散乱光を検出する代謝情報測定用プロー
ブに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a probe for measuring metabolic information, and more particularly, to a probe for measuring metabolic information which irradiates near-infrared light and detects scattered light transmitted through the inside of an object to be measured.

【0002】[0002]

【従来の技術】近赤外光を照射して測定対象の内部を透
過した散乱光を検出する代謝情報測定用プローブは、従
来より種々のものが提案されていて、例えば心臓の心筋
の代謝測定を行う際に用いられている。
2. Description of the Related Art Various types of metabolic information measurement probes for detecting scattered light transmitted through the inside of a measurement object by irradiating near-infrared light have hitherto been proposed. It is used when performing.

【0003】このような代謝情報測定用プローブの一例
として、例えば特開平7−380号公報には、可撓性の
挿入部と、この挿入部先端より前方に光を出射する出射
端面が該挿入部先端面に設けられた出射手段と、この出
射手段から出射された光による観察体の光学情報を受光
する受光端面が前記挿入部先端面に設けられた受光手段
とを備え、前記出射端面及び前記受光端面が互いに反対
方向に、外方に向けて傾斜している酸素代謝測定装置が
記載されている。
As an example of such a probe for measuring metabolic information, for example, Japanese Patent Laid-Open No. 7-380 discloses a flexible insertion portion and an emission end face for emitting light forward from the tip of the insertion portion. A light-receiving means provided on the distal end face of the insertion portion, the light-receiving means being provided on the distal end face of the insertion portion, and a light-receiving end face for receiving optical information of the observation object by light emitted from the light-emitting section. An oxygen metabolism measuring device is described in which the light receiving end faces are inclined outward in opposite directions.

【0004】また、例えば脳組織等の体内器官の機能を
診断する際に、体内器官内の酸素量が十分なものであっ
て適切に利用されているか否かは、基本的かつ重要なパ
ラメータとなる。
[0004] In diagnosing the function of internal organs such as brain tissue, for example, whether or not the amount of oxygen in the internal organs is sufficient and used properly is a basic and important parameter. Become.

【0005】このような体内器官の酸素量を早期にかつ
容易に診断するために、チトクロームやヘモグロビンな
どを吸光度測定することにより代謝情報を取得する手段
が従来より開発されていて、例えば米国特許42816
45号にその詳しい原理や構成などが説明されており、
また、この米国特許4281645号に記載された内容
を簡単に説明したものとしては特開昭63−27703
8号公報が一例として挙げられる。
[0005] In order to quickly and easily diagnose the oxygen content of organs in the body, a means for obtaining metabolic information by measuring the absorbance of cytochrome, hemoglobin or the like has been conventionally developed. For example, US Pat.
No.45 explains its detailed principle and configuration.
A brief description of the contents described in U.S. Pat. No. 4,281,645 is disclosed in JP-A-63-27703.
No. 8 is cited as an example.

【0006】[0006]

【発明が解決しようとする課題】しかしながら、上記特
開平7−380号公報に記載されたような形状のプロー
ブにより心外膜側から代謝測定を行う場合には、プロー
ブを心筋に対してほぼ垂直状態にして接触させる必要が
あるが、拍動している心臓に対して一定時間、ほぼ垂直
状態に接触させていることは難しく、プローブが心筋か
ら離れてしまったり、あるいは、プローブが傾いてしま
ったりすることが少なくなかった。
However, when a metabolic measurement is performed from the epicardium side using a probe having the shape described in JP-A-7-380, the probe must be substantially perpendicular to the myocardium. However, it is difficult to keep the heart in contact with the beating heart in a nearly vertical state for a certain period of time, and the probe may be separated from the myocardium or the probe may be tilted. There were many things to roll around.

【0007】また、プローブ先端部の照射端面および受
光端面は、互いに略反対方向を向くように設けられてい
るために、心外膜側からプローブを心筋に接触させた場
合には蛍光灯などの外乱光が心筋により反射されて、そ
の反射光が受光端面から入射してノイズが大きくなって
しまうことがあった。
Further, since the irradiation end face and the light reception end face of the probe tip are provided so as to face in directions substantially opposite to each other, when the probe is brought into contact with the myocardium from the epicardium side, a fluorescent lamp or the like is used. In some cases, disturbance light is reflected by the myocardium, and the reflected light is incident from the light receiving end face to increase noise.

【0008】このようにして、従来の代謝情報測定用プ
ローブを用いて、測定対象として拍動している心臓の心
筋の代謝測定を心外膜側から行う場合には、操作性が良
いとはいえず、代謝情報が得られなかったり、得られた
としても信頼性が低くなってしまうことがあった。
[0008] In this manner, when the metabolic measurement of the beating myocardium is performed from the epicardium side using the conventional probe for measuring metabolic information, the operability is not good. In other words, metabolic information could not be obtained, or even if obtained, reliability was low.

【0009】本発明は上記事情に鑑みてなされたもので
あり、変動する測定対象について、操作性良く確実に測
定を行うことができる代謝情報測定用プローブを提供す
ることを目的としている。
The present invention has been made in view of the above circumstances, and it is an object of the present invention to provide a metabolic information measuring probe capable of reliably measuring a fluctuating measurement object with good operability.

【0010】[0010]

【課題を解決するための手段】上記の目的を達成するた
めに、第1の発明による代謝情報測定用プローブは、光
源から発せられる近赤外光を当該プローブの先端部に配
設された照射端面から照射して測定対象まで導く照射光
導光手段と、この照射光導光手段により照射されて上記
測定対象の内部を透過した散乱光を当該プローブの先端
部に配設された受光端面から入射して検出手段まで導く
散乱光導光手段と、上記照射光導光手段の照射端面およ
び上記散乱光導光手段の受光端面を上記測定対象に対し
て接触させる際に当該プローブの先端部を保持するため
の保持手段とを備えたものである。
In order to achieve the above object, a metabolic information measuring probe according to a first aspect of the present invention uses near-infrared light emitted from a light source for irradiating near-infrared light disposed at the tip of the probe. Irradiating light guide means for irradiating from the end face and guiding to the object to be measured, and scattered light radiated by the irradiating light guide means and transmitted through the inside of the object to be measured is incident from a light receiving end face provided at the tip of the probe. Scattered light guiding means for guiding to the detection means, and holding for holding the tip of the probe when the irradiation end face of the irradiation light guiding means and the light receiving end face of the scattered light guiding means are brought into contact with the object to be measured. Means.

【0011】また、第2の発明による代謝情報測定用プ
ローブは、上記第1の発明による代謝情報測定用プロー
ブにおいて、上記保持手段がバンド状をなして構成され
ているものである。
The probe for measuring metabolic information according to the second invention is the probe for measuring metabolic information according to the first invention, wherein the holding means is formed in a band shape.

【0012】さらに、第3の発明による代謝情報測定用
プローブは、上記第1または第2の発明による代謝情報
測定用プローブにおいて、上記保持手段が突起状をなし
て構成されているものである。
Further, a metabolic information measuring probe according to a third aspect of the present invention is the metabolic information measuring probe according to the first or second aspect of the present invention, wherein the holding means has a projection shape.

【0013】従って、第1の発明による代謝情報測定用
プローブは、照射光導光手段の照射端面および散乱光導
光手段の受光端面を測定対象に対して接触させる際に、
保持手段により当該プローブの先端部を保持し、照射光
導光手段が光源から発せられる近赤外光を当該プローブ
の先端部に配設された照射端面から照射して測定対象ま
で導き、散乱光導光手段がこの照射光導光手段により照
射されて上記測定対象の内部を透過した散乱光を当該プ
ローブの先端部に配設された受光端面から入射して検出
手段まで導く。
Therefore, the probe for measuring metabolic information according to the first aspect of the present invention, when bringing the irradiation end face of the irradiation light guide means and the light receiving end face of the scattered light guide means into contact with the object to be measured,
The tip of the probe is held by the holding means, and the irradiation light guide means irradiates near-infrared light emitted from the light source from the irradiation end face provided at the tip of the probe to guide the light to the measurement object, and the scattered light guide A means irradiates the scattered light radiated by the irradiating light guide means and transmitted through the inside of the object to be measured from the light receiving end face provided at the tip of the probe to guide the scattered light to the detecting means.

【0014】また、第2の発明による代謝情報測定用プ
ローブは、術者が指先にバンド状をなす保持手段を装着
して使用する。
In the probe for measuring metabolic information according to the second invention, a surgeon attaches a band-shaped holding means to a fingertip for use.

【0015】さらに、第3の発明による代謝情報測定用
プローブは、術者が指により突起状をなす保持手段を摘
んで使用する。
Further, in the probe for measuring metabolic information according to the third aspect of the present invention, the surgeon uses a finger to pinch a protruding holding means with a finger.

【0016】[0016]

【発明の実施の形態】以下、図面を参照して本発明の実
施の形態を説明する。図1から図5は本発明の第1の実
施形態を示したものであり、図1は代謝情報測定装置の
全体的な構成を示すブロック図、図2はプローブの先端
部を示す縦断面図、図3はプローブの先端部を示す横断
面図、図4は術者の指先に保持手段を装着して先端部を
心筋に接触させた状態を示す斜視図およびその拡大斜視
図、図5は術者の指先に保持手段を装着して先端部を心
筋に接触させた状態を示す断面図である。
Embodiments of the present invention will be described below with reference to the drawings. 1 to 5 show a first embodiment of the present invention. FIG. 1 is a block diagram showing an overall configuration of a metabolic information measuring device, and FIG. 2 is a longitudinal sectional view showing a tip portion of a probe. FIG. 3 is a cross-sectional view showing the distal end of the probe, FIG. 4 is a perspective view showing the state where the holding means is attached to the operator's fingertip and the distal end is brought into contact with the myocardium, and its enlarged perspective view. It is sectional drawing which shows the state which attached the holding | maintenance means to an operator's fingertip, and made the front-end | tip part contact myocardium.

【0017】この代謝情報測定装置は、図1に示すよう
に、制御装置1と、この制御装置1に着脱自在に接続さ
れている代謝情報測定用プローブ(以下、プローブとい
う)10とを有して構成されている。
As shown in FIG. 1, the metabolic information measuring device has a control device 1 and a metabolic information measuring probe (hereinafter, referred to as a probe) 10 detachably connected to the control device 1. It is configured.

【0018】上記制御装置1は、波長が異なる複数の図
示しない光源(例えば半導体レーザー、LEDなど)を
有する照射手段2と、測定対象たる心筋に照射される照
射光強度を測定して電気信号に変換する検出手段(例え
ばPMT、PDなど)を有する参照光受光手段3と、心
筋深部に至り透過してきた散乱光強度を測定して電気信
号に変換する検出手段(例えばPMT、PDなど)を有
する受光手段4と、上記照射手段2を制御するとともに
これに同期して上記参照光受光手段3と受光手段4によ
り変換された電気信号から心筋の代謝情報を演算処理す
る制御手段5とを有して構成されている。
The control device 1 includes an irradiating means 2 having a plurality of light sources (not shown) (for example, a semiconductor laser, an LED, etc.) having different wavelengths, and measures the intensity of the irradiating light applied to the myocardium to be measured and converts the intensity into an electric signal. There is a reference light receiving unit 3 having a detecting unit (for example, PMT, PD, etc.) for conversion, and a detecting unit (for example, PMT, PD, etc.) for measuring the intensity of scattered light transmitted to the deep part of the myocardium and converting it into an electric signal. A light receiving means 4 and a control means 5 for controlling the irradiating means 2 and, in synchronization therewith, calculating and processing myocardial metabolic information from the electrical signals converted by the reference light receiving means 3 and the light receiving means 4 It is configured.

【0019】上記プローブ10は、上記照射手段2から
の光を導通する照射光導光手段たる照射用ファイバ11
と、この照射用ファイバ11の一端部に取り付けられた
着脱自在の照射用コネクタ12と、上記参照光受光手段
3へ参照光を導通する参照用ファイバ13と、この参照
用ファイバ13の一端部に取り付けられた着脱自在の参
照用コネクタ14と、受光した散乱光を上記受光手段4
へ導通する散乱光導光手段たる受光用ファイバ15と、
この受光用ファイバ15の一端部に取り付けられた着脱
自在の受光用コネクタ16と、上記照射用ファイバ1
1,参照用ファイバ13,受光用ファイバ15を結束し
て覆っている伸張可能かつ細径なフレキシブルチューブ
により構成されたユニバーサルコード17と、このユニ
バーサルコード17の先端側に設けられた保持手段19
を有する先端部18とを有して構成されている。
The probe 10 has an irradiation fiber 11 serving as an irradiation light guiding means for conducting the light from the irradiation means 2.
A detachable irradiation connector 12 attached to one end of the irradiation fiber 11, a reference fiber 13 for conducting reference light to the reference light receiving means 3, and one end of the reference fiber 13. The detachable reference connector 14 attached and the scattered light received
A light receiving fiber 15 serving as a scattered light guiding means that conducts to the
A detachable light-receiving connector 16 attached to one end of the light-receiving fiber 15;
1, a universal cord 17 composed of an extensible and small-diameter flexible tube that binds and covers the reference fiber 13 and the light receiving fiber 15, and holding means 19 provided on the distal end side of the universal cord 17.
And a distal end portion 18 having the same.

【0020】次に、図2,図3を参照して上記先端部1
8について説明する。
Next, referring to FIG. 2 and FIG.
8 will be described.

【0021】この先端部18は、上記照射用ファイバ1
1の出射端が光学的に接続されていてその光の出射方向
を直角方向に変換するプリズム等で構成されるとともに
上記参照用ファイバ13の入射端が接続されている照射
端面25と、上記受光用ファイバ15の入射端が光学的
に接続されていて同様に光の入射方向を直角方向に変換
するプリズム等で構成される受光端面26とを有して構
成されている。
The tip 18 is connected to the irradiation fiber 1.
An irradiation end face 25, which is optically connected to the output end of the optical fiber 1 and is configured by a prism or the like for converting the light emission direction to a right angle direction, and to which the input end of the reference fiber 13 is connected, The input end of the optical fiber 15 is optically connected and similarly has a light receiving end surface 26 formed of a prism or the like that converts the incident direction of light into a right angle direction.

【0022】さらにこの先端部18には、心筋接触面側
である照射端面25と受光端面26が設けられている側
とは反対側に、術者の指先に装着して使用するためのベ
ルト状(輪状)をなす保持手段19が設けられている。
この保持手段19のベルトの長さ(輪の円周の長さ)
は、指に装着可能な長さであって、かつ指先から外れな
い程度の長さであることが望ましい。
Further, the distal end portion 18 is provided on the opposite side to the side where the irradiation end face 25 and the light receiving end face 26, which are the myocardial contact surfaces, are provided. A (ring-shaped) holding means 19 is provided.
Length of the belt of this holding means 19 (length of the circumference of the ring)
Is desirably a length that can be worn on a finger and that does not come off the fingertip.

【0023】続いて、このような実施形態の作用を説明
する。
Next, the operation of such an embodiment will be described.

【0024】制御装置1を操作することにより、制御手
段5の制御に基づいて照射手段2から4つの異なる波長
のパルス光が順次照射される。これらの波長は、酸素代
謝情報に関係するチトクローム、ヘモグロビン等に吸収
のある700〜950nmの4波長の近赤外光である。
By operating the control device 1, pulse light of four different wavelengths is sequentially irradiated from the irradiation unit 2 under the control of the control unit 5. These wavelengths are near-infrared light of four wavelengths from 700 to 950 nm, which absorb cytochrome, hemoglobin, and the like related to oxygen metabolism information.

【0025】これらの照射光は、照射用コネクタ12を
介して照射用ファイバ11に入射し、この照射用ファイ
バ11により導光されて、先端部18に到達する。そし
て、先端部18の照射端面25を介して、心筋に順次照
射される。
The irradiation light enters the irradiation fiber 11 via the irradiation connector 12, is guided by the irradiation fiber 11, and reaches the distal end 18. Then, the myocardium is sequentially irradiated through the irradiation end face 25 of the distal end portion 18.

【0026】この心筋に照射された照射光の内の、心筋
表面もしくは心筋表面から浅い部分からの反射光は、上
記照射端面25および参照用ファイバ13を介して参照
光受光手段3により受光され、照射光強度として検出さ
れる。
Of the irradiation light applied to the myocardium, the reflected light from the myocardial surface or a portion shallow from the myocardial surface is received by the reference light receiving means 3 via the irradiation end face 25 and the reference fiber 13, and It is detected as irradiation light intensity.

【0027】一方、心筋に照射された照射光は、組織に
よる光散乱のために、心筋組織内を拡散しながら透過す
る。この散乱光の一部は、照射端面25から約5mm〜
約1cm程度離れた受光端面26を介して入射し、受光
用ファイバ15と受光用コネクタ16を介して受光手段
4により受光されて、散乱光強度として検出される。従
って、心筋組織の深部を透過した散乱光強度を捕らえる
ことができる。
On the other hand, the irradiation light applied to the myocardium is transmitted while diffusing in the myocardial tissue due to light scattering by the tissue. Part of this scattered light is approximately 5 mm from the irradiation end face 25.
The light enters through a light receiving end surface 26 which is about 1 cm away, is received by the light receiving means 4 via the light receiving fiber 15 and the light receiving connector 16, and is detected as scattered light intensity. Therefore, the intensity of the scattered light transmitted through the deep part of the myocardial tissue can be captured.

【0028】こうして、それぞれ異なる4つの波長の照
射光を順次検出して、それぞれの波長の照射光強度と散
乱光強度を制御手段5で相互に演算処理することによ
り、ヘモグロビン、チトクロームの酸素飽和度を求める
ことができる。この求められた結果は、制御装置1に設
けられている図示しない表示部に表示される。
In this way, the irradiation light of four different wavelengths is sequentially detected, and the irradiation light intensity and the scattered light intensity of each wavelength are mutually processed by the control means 5, thereby obtaining the oxygen saturation of hemoglobin and cytochrome. Can be requested. The obtained result is displayed on a display unit (not shown) provided in the control device 1.

【0029】なお、上記従来の技術で述べたように、チ
トクロームやヘモグロビンなどの吸光度測定による代謝
情報取得の原理や手段などは、米国特許4281645
号に詳しい説明が、また特開昭63−277038号公
報に簡単な説明が記載されている。
As described in the above prior art, the principle and means of obtaining metabolic information by measuring absorbance of cytochrome and hemoglobin are described in US Pat. No. 4,281,645.
The detailed description is described in the Japanese Patent Application Laid-Open No. 63-277038, and the brief description is described in Japanese Patent Application Laid-Open No. 63-277038.

【0030】すなわち、これらに記載の手段では、血液
中の酸素運搬媒体であるヘモグロビンと、酸素還元反応
を行う細胞中のチトクロームa,a3 とによる近赤外光
の吸収スペクトルに基づいて、測定対象の酸素量を測定
するようになっている。
That is, in the means described in these documents, the measurement object is determined based on the absorption spectrum of near-infrared light by hemoglobin, which is an oxygen transport medium in blood, and cytochromes a, a3 in cells that undergo an oxygen reduction reaction. The amount of oxygen is measured.

【0031】より詳しくは、酸素と結合したヘモグロビ
ン(HbO2 )と酸素の取り除かれたヘモグロビン(H
b)とは、700〜1300nm程度の波長の近赤外光
による吸収スペクトルが異なり、同様に、酸化されたチ
トクロームa,a3 (CyO2 )と還元されたチトクロ
ームa,a3 (Cy)とは吸収スペクトルが異なる。こ
れを利用して、測定対象に例えば4種類の異なる波長
(一例として、775nm,800nm,825nm,
850mn)の近赤外光を時分割して照射し、該測定対
象を透過した光を検出して所定の演算処理を施すこと
で、上記4つの未知数、すなわち、酸素と結合したヘモ
グロビン(HbO2 )、酸素の取り除かれたヘモグロビ
ン(Hb)、酸化されたチトクロームa,a3 (CyO
2 )、還元されたチトクロームa,a3 (Cy)の各濃
度変化量を算出し、これらに基づいて測定対象の酸素量
の変化を測定するようになっている。
More specifically, hemoglobin (HbO 2) bound to oxygen and hemoglobin (H
b) differs from the absorption spectrum by near-infrared light having a wavelength of about 700 to 1300 nm. Similarly, the absorption spectra of oxidized cytochromes a and a3 (CyO2) and reduced cytochromes a and a3 (Cy) are similar. Are different. By utilizing this, for example, four types of different wavelengths (for example, 775 nm, 800 nm, 825 nm,
850 mn) of near-infrared light is radiated in a time-division manner, and the light transmitted through the object to be measured is detected and subjected to a predetermined arithmetic processing, whereby the above-mentioned four unknowns, namely, hemoglobin (HbO 2) combined with oxygen are obtained. , Deoxygenated hemoglobin (Hb), oxidized cytochromes a, a3 (CyO
2) The amount of change in each concentration of reduced cytochromes a and a3 (Cy) is calculated, and the change in the amount of oxygen to be measured is measured based on these.

【0032】次に、使用方法の一例として、心筋の代謝
情報測定を行う場合、つまり、心筋Viability(心筋生
死判別)評価法を行う場合について、図4,図5を参照
して説明する。
Next, as an example of the method of use, a case where the metabolic information of the myocardium is measured, that is, a case where the myocardial viability (cardiac viability discrimination) evaluation method is performed will be described with reference to FIGS.

【0033】例えばCABG(冠動脈バイパス術)など
の外科的治療を行う場合には、図4に示すように患者の
開胸を行って、心臓を直接処置することができるような
状態にする。
For example, when performing a surgical treatment such as CABG (coronary artery bypass surgery), the patient is opened as shown in FIG. 4 so that the heart can be directly treated.

【0034】そして術者の指先に上記保持手段19を装
着し、心筋Viability(心筋生死判別)評価を行う領域
の心筋表面に図4,図5に示すようにプローブ10の先
端部18を接触させて、照射手段2から上述したような
異なる4波長の近赤外光を順次照射する。このときに、
制御装置1の上記図示しない表示部において、チトクロ
ームやヘモグロビンなどの代謝に関するデータが安定し
て得られていることを確認する。
Then, the holding means 19 is attached to the fingertip of the operator, and the distal end portion 18 of the probe 10 is brought into contact with the myocardial surface in the region where the myocardial viability (cardiac viability discrimination) evaluation is performed as shown in FIGS. Then, the irradiation means 2 sequentially irradiates near infrared light of four different wavelengths as described above. At this time,
It is confirmed on the display unit (not shown) of the control device 1 that data on metabolism of cytochrome, hemoglobin, and the like is stably obtained.

【0035】その後、図示しないペースメーカーなどに
より現状の心拍数よりも速い心拍数にペーシングを行
い、心臓に負荷を、つまり代謝変化を与える。こうして
一定期間だけ代謝変化を与えた後に、ペーシングを終了
させる。
Thereafter, pacing is performed by a pacemaker or the like (not shown) to a heart rate faster than the current heart rate, thereby imposing a load on the heart, that is, giving a metabolic change. After giving a metabolic change for a certain period in this way, pacing is terminated.

【0036】上述した一連の手順において、代謝変化を
伴うチトクロームやヘモグロビンなどのパラメータの相
対的変化を上記表示部により観察する。
In the above-described series of procedures, relative changes in parameters such as cytochrome and hemoglobin accompanied by metabolic changes are observed on the display unit.

【0037】チトクロームが代謝変化に伴って変化した
場合にはViability有り(心筋生存)と判断され、一
方、チトクロームが代謝変化にも関わらず変化しない場
合にはViability無し(心筋壊死)と判断される。
When cytochrome changes with metabolic change, it is determined that viability is present (heart muscle survival). On the other hand, when cytochrome does not change despite metabolic change, it is determined that there is no viability (cardiac necrosis). .

【0038】以上の手順を心筋の位置を変えながら順次
行って、心筋の生存範囲あるいは壊死範囲を確定し、こ
れらの情報に基づいて必要な治療を行う。
The above procedure is sequentially performed while changing the position of the myocardium to determine the survival range or necrosis range of the myocardium, and perform necessary treatment based on the information.

【0039】なお、上述では照射端面25と受光端面2
6をプリズムにより構成して心筋への光の照射および心
筋からの散乱光の受光を行うように構成したが、これに
限るものではなく、例えば照射用ファイバ11、参照用
ファイバ13および受光用ファイバ15を先端部18の
内部でそれぞれ曲折することにより、これらのファイバ
の端面から、照射光を心筋に直接照射するとともに、参
照光および散乱光を直接受光するように構成しても良
い。
In the above description, the irradiation end face 25 and the light receiving end face 2
6 is constituted by a prism to irradiate light to the myocardium and receive scattered light from the myocardium. However, the present invention is not limited to this. For example, the irradiation fiber 11, the reference fiber 13, and the light-receiving fiber By bending each of the fibers 15 inside the distal end portion 18, irradiation light may be directly applied to the myocardium from the end faces of these fibers, and reference light and scattered light may be directly received.

【0040】このような第1の実施形態によれば、プロ
ーブの先端部に保持手段を設けたために、該先端部を、
拍動している心臓の心筋から離れることなく追従させる
ことができ、確実に代謝情報を測定することができる。
According to the first embodiment, since the holding means is provided at the tip of the probe, the tip is
It is possible to follow the beating heart without departing from the myocardium, and it is possible to reliably measure metabolic information.

【0041】そして、先端部を心筋に接触して使用する
ことができるために、所望の領域(局所領域)の心筋代
謝情報を測定することが可能になる。
Since the tip can be used in contact with the myocardium, it is possible to measure myocardial metabolic information of a desired region (local region).

【0042】図6から図9は本発明の第2の実施形態を
示したものであり、図6はプローブの先端部を示す斜視
図、図7はプローブの先端部を示す縦断面図、図8はプ
ローブの先端部を示す横断面図、図9は術者の指先によ
り保持手段を摘んで先端部を心筋に接触させた状態を示
す断面図である。
FIGS. 6 to 9 show a second embodiment of the present invention. FIG. 6 is a perspective view showing the tip of the probe, and FIG. 7 is a longitudinal sectional view showing the tip of the probe. 8 is a cross-sectional view showing the distal end of the probe, and FIG. 9 is a cross-sectional view showing a state in which the holding means is pinched by the operator's fingertip to bring the distal end into contact with the myocardium.

【0043】この第2の実施形態において、上述の第1
の実施形態と同様である部分については同一の符号を付
して説明を省略し、主として異なる点についてのみ説明
する。
In the second embodiment, the first
The same components as those of the first embodiment are denoted by the same reference numerals, and description thereof will be omitted. Only different points will be mainly described.

【0044】この第2の実施形態は、先端部18に設け
た保持手段の形状を異なる構成とし、さらに照射端面2
5および受光端面26の配置を変更したものである。
In the second embodiment, the shape of the holding means provided at the distal end portion 18 is different from that of the irradiation end face 2.
5 and the arrangement of the light receiving end face 26 are changed.

【0045】すなわち、本実施形態の保持手段30は、
図6,図7,図8に示すように、先端部18の心筋接触
面側である照射端面25と受光端面26が設けられてい
る側とは反対側に、術者が指で摘んで使用するための、
先端頭部を有する柱状突起でなる保持手段30が設けら
れている。
That is, the holding means 30 of the present embodiment comprises:
As shown in FIG. 6, FIG. 7, and FIG. 8, the operator grasps the distal end portion 18 with the finger on the side opposite to the side where the irradiation end surface 25 and the light receiving end surface 26, which are the myocardial contact surface side, are provided. in order to,
A holding means 30 composed of a columnar projection having a head end is provided.

【0046】また、この先端部18に設けられた照射端
面25と受光端面26は、前方から見た場合に、互いに
反対方向に傾斜するように設けられている。つまり、照
射端面25をその光の出射方向が上記受光端面26から
やや遠ざかるように外側に向けて、また、受光端面26
を光の入射方向が上記照射端面25からやや遠ざかるよ
うに外側に向けて、それぞれ配設している。
Further, the irradiation end face 25 and the light receiving end face 26 provided at the distal end portion 18 are provided so as to be inclined in opposite directions when viewed from the front. That is, the irradiation end face 25 is directed outward so that the emission direction of the light is slightly away from the light receiving end face 26.
Are directed outward so that the light incident direction is slightly away from the irradiation end face 25.

【0047】次に、このような第2の実施形態の代謝情
報測定装置の作用は、上述の第1の実施形態とほぼ同様
であるが、心筋の代謝情報測定を行う際に、図9に示す
ように、術者が保持手段30を指で摘んで、先端部18
を心筋に接触させるようになっている。
Next, the operation of the metabolic information measuring apparatus of the second embodiment is almost the same as that of the above-described first embodiment. As shown, the operator grasps the holding means 30 with a finger, and
Is brought into contact with the myocardium.

【0048】また、照射端面25から照射された光は、
より円に近い弧状の散乱経路を描いて受光端面26に到
達する。
The light irradiated from the irradiation end face 25 is
The light arrives at the light-receiving end face 26 by drawing an arc-shaped scattering path closer to a circle.

【0049】このような第2の実施形態によれば、上述
の第1の実施形態とほぼ同様の効果を奏するとともに、
保持手段が指で摘むタイプのものであるために、指先に
装着する必要がなく、保持動作が容易である。
According to the second embodiment, substantially the same effects as those of the first embodiment can be obtained.
Since the holding means is of a finger-pick type, there is no need to attach it to the fingertip, and the holding operation is easy.

【0050】また、照射端面と受光端面を互いに反対方
向に傾斜して配設したために、心筋内を透過する散乱光
の光学的経路がより長くなり、照射端面と受光端面をよ
り近接させて配置することが可能となって、プローブ先
端部の小型化を図ることが可能となる。
Further, since the irradiation end face and the light reception end face are arranged to be inclined in opposite directions to each other, the optical path of the scattered light transmitted through the myocardium becomes longer, and the irradiation end face and the light reception end face are arranged closer to each other. The size of the probe tip can be reduced.

【0051】図10から図14は本発明の第3の実施形
態を示したものであり、図10はプローブの先端部を示
す斜視図、図11はプローブの先端部を示す底面図、図
12はプローブの先端部を示す縦断面図、図13はプロ
ーブの先端部を示す横断面図、図14はプローブの先端
部を心筋に接触させた状態を示す断面図である。
FIGS. 10 to 14 show a third embodiment of the present invention. FIG. 10 is a perspective view showing the tip of the probe, FIG. 11 is a bottom view showing the tip of the probe, and FIG. Is a longitudinal sectional view showing the distal end of the probe, FIG. 13 is a transverse sectional view showing the distal end of the probe, and FIG. 14 is a sectional view showing a state where the distal end of the probe is brought into contact with the myocardium.

【0052】この第3の実施形態において、上述の第
1,第2の実施形態と同様である部分については同一の
符号を付して説明を省略し、主として異なる点について
のみ説明する。
In the third embodiment, the same parts as those in the above-described first and second embodiments are denoted by the same reference numerals, and description thereof will be omitted. Only different points will be mainly described.

【0053】本実施形態のプローブ10の先端部18
は、上述の第1の実施形態と同様の保持手段19を有す
るとともに、照射端面25と受光端面26を上述の第2
の実施形態と同様に配置し、さらに、その心筋接触面に
外乱光を遮断するための遮光手段35を設けたものであ
る。
The tip 18 of the probe 10 according to the present embodiment
Has the same holding means 19 as in the above-described first embodiment, and has the irradiation end face 25 and the light receiving end face 26 in the above-described second embodiment.
And a light shielding means 35 for blocking disturbance light is provided on the myocardial contact surface.

【0054】この遮光手段35は、先端部18の心筋接
触面に、照射端面25および受光端面26を囲む外周壁
状の凸部として設けられている。なお、この遮光手段3
5の高さとしては、先端部18を心筋に接触させた場合
に、該遮光手段35が心筋に食い込むとともに、かつ、
照射端面25および受光端面26も心筋に接触するよう
な高さであることが望ましい(図14参照)。
The light shielding means 35 is provided on the myocardial contact surface of the distal end portion 18 as an outer peripheral wall-shaped projection surrounding the irradiation end face 25 and the light receiving end face 26. The light shielding means 3
As the height of 5, when the distal end portion 18 is brought into contact with the myocardium, the light shielding means 35 bites into the myocardium, and
It is desirable that the irradiation end face 25 and the light receiving end face 26 also have such a height that they come into contact with the myocardium (see FIG. 14).

【0055】次に、このような第3の実施形態の代謝情
報測定装置の作用は上述の第1,第2の実施形態とほぼ
同様であるが、先端部18を心筋に接触させると、図1
4に示すように、照射端面25と受光端面26が心筋に
接触するとともに、遮光手段35も心筋を凹状に押圧し
た状態で接触する。
Next, the operation of the metabolic information measuring apparatus of the third embodiment is almost the same as that of the above-described first and second embodiments. 1
As shown in FIG. 4, the irradiation end face 25 and the light receiving end face 26 come into contact with the myocardium, and the light shielding means 35 comes into contact with the myocardium while pressing the myocardium in a concave shape.

【0056】このような状態においては、照射端面25
および受光端面26を囲む周壁状の凸部をなす遮光手段
35の作用により、先端部18の心筋接触面に蛍光灯な
どの外乱光が入射することはない。
In such a state, the irradiation end face 25
The disturbance light such as a fluorescent lamp does not enter the myocardial contact surface of the distal end portion 18 by the action of the light shielding means 35 which forms a peripheral wall-shaped convex portion surrounding the light receiving end surface 26.

【0057】このような第3の実施形態によれば、上述
の第1,第2の実施形態とほぼ同様の効果を奏するとと
もに、先端部の心筋接触面に遮光手段を設けたことによ
り、外乱光の影響を受けることなく、精度良く心筋の代
謝情報を測定することができる。
According to the third embodiment, substantially the same effects as those of the first and second embodiments can be obtained, and since the light shielding means is provided on the myocardial contact surface at the distal end, the disturbance can be improved. Without being affected by light, metabolic information of the myocardium can be accurately measured.

【0058】なお、本発明は上述した各実施形態に限定
されるものではなく、発明の主旨を逸脱しない範囲内に
おいて種々の変形や応用が可能であることは勿論であ
る。
It should be noted that the present invention is not limited to the above-described embodiments, and various modifications and applications are of course possible without departing from the spirit of the invention.

【0059】[付記]以上詳述したような本発明の上記
実施形態によれば、以下のごとき構成を得ることができ
る。
[Appendix] According to the above-described embodiment of the present invention as described in detail above, the following configuration can be obtained.

【0060】(1) 光源から発せられる近赤外光を当
該プローブの先端部に配設された照射端面から照射して
測定対象まで導く照射光導光手段と、この照射光導光手
段により照射されて上記測定対象の内部を透過した散乱
光を当該プローブの先端部に配設された受光端面から入
射して検出手段まで導く散乱光導光手段と、上記照射光
導光手段の照射端面および上記散乱光導光手段の受光端
面を上記測定対象に対して接触させる際に当該プローブ
の先端部を保持するための保持手段と、を具備したこと
を特徴とする代謝情報測定用プローブ。
(1) Irradiation light guide means for irradiating near-infrared light emitted from the light source from the irradiation end face provided at the tip of the probe to guide it to the object to be measured; Scattered light guiding means for guiding the scattered light transmitted through the inside of the measurement object from the light receiving end face disposed at the tip of the probe to the detecting means, the irradiation end face of the irradiation light guiding means and the scattered light guide A metabolic information measurement probe, comprising: a holding means for holding a tip of the probe when the light receiving end face of the means is brought into contact with the measurement object.

【0061】(2) 上記保持手段は、バンド状をなし
て構成されていることを特徴とする付記(1)に記載の
代謝情報測定用プローブ。
(2) The probe for measuring metabolic information according to (1), wherein the holding means is formed in a band shape.

【0062】(3) 上記保持手段は、突起状をなして
構成されていることを特徴とする付記(1)に記載の代
謝情報測定用プローブ。
(3) The metabolic information measurement probe according to (1), wherein the holding means is formed in a projecting shape.

【0063】(4) 当該プローブの先端部に、上記照
射光導光手段の照射端面および上記散乱光導光手段の受
光端面を外乱光から遮光するための遮光手段を設けたこ
とを特徴とする付記(1)に記載の代謝情報測定用プロ
ーブ。
(4) At the tip of the probe, a light shielding means for shielding the irradiation end face of the irradiation light guiding means and the light receiving end face of the scattered light guiding means from disturbance light is provided. The probe for measuring metabolic information according to 1).

【0064】これによれば、外乱光の影響を受けること
なく、精度良く測定を行うことができる。
According to this, the measurement can be performed with high accuracy without being affected by disturbance light.

【0065】(5) 上記照射光導光手段の照射端面と
上記散乱光導光手段の受光端面は、互いに離反する方向
を向くようにやや傾斜して配設されていることを特徴と
する付記(1)、付記(2)、付記(3)、または付記
(4)に記載の代謝情報測定用プローブ。
(5) An additional feature (1) is that the irradiation end face of the irradiation light guide means and the light receiving end face of the scattered light guide means are slightly inclined so as to face in directions away from each other. And (2), (3) and (4).

【0066】これによれば、測定対象を透過する散乱光
の光学的経路がより長くなり、照射端面と受光端面をよ
り近接させて配置することが可能となるために、先端部
の小型化を図ることが可能となる。
According to this, the optical path of the scattered light transmitted through the object to be measured becomes longer, and the irradiation end face and the light reception end face can be arranged closer to each other. It becomes possible to plan.

【0067】[0067]

【発明の効果】以上説明したように本発明の代謝情報測
定用プローブによれば、変動する測定対象について、操
作性良く確実に測定を行うことができる。
As described above, according to the probe for measuring metabolic information of the present invention, it is possible to reliably measure an object to be measured with good operability.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の第1の実施形態の代謝情報測定装置の
全体的な構成を示すブロック図。
FIG. 1 is a block diagram showing an overall configuration of a metabolic information measuring device according to a first embodiment of the present invention.

【図2】上記第1の実施形態のプローブの先端部を示す
縦断面図。
FIG. 2 is a longitudinal sectional view showing a distal end portion of the probe according to the first embodiment.

【図3】上記第1の実施形態のプローブの先端部を示す
横断面図。
FIG. 3 is a cross-sectional view showing a distal end portion of the probe according to the first embodiment.

【図4】上記第1の実施形態において、術者の指先に保
持手段を装着して先端部を心筋に接触させた状態を示す
斜視図およびその拡大斜視図。
FIG. 4 is a perspective view and a magnified perspective view showing a state in which a holding unit is attached to a fingertip of an operator and a distal end portion is brought into contact with a myocardium in the first embodiment.

【図5】上記第1の実施形態において、術者の指先に保
持手段を装着して先端部を心筋に接触させた状態を示す
断面図。
FIG. 5 is a cross-sectional view showing a state in which the holding means is attached to the operator's fingertip and the distal end is brought into contact with the myocardium in the first embodiment.

【図6】本発明の第2の実施形態のプローブの先端部を
示す斜視図。
FIG. 6 is a perspective view showing a distal end portion of a probe according to a second embodiment of the present invention.

【図7】上記第2の実施形態のプローブの先端部を示す
縦断面図。
FIG. 7 is a longitudinal sectional view showing a distal end portion of the probe according to the second embodiment.

【図8】上記第2の実施形態のプローブの先端部を示す
横断面図。
FIG. 8 is a cross-sectional view showing a distal end portion of the probe according to the second embodiment.

【図9】上記第2の実施形態において、術者の指先によ
り保持手段を摘んで先端部を心筋に接触させた状態を示
す断面図。
FIG. 9 is a cross-sectional view showing a state in which the holding means is pinched by a fingertip of an operator to bring a distal end portion into contact with a myocardium in the second embodiment.

【図10】本発明の第3の実施形態のプローブの先端部
を示す斜視図。
FIG. 10 is a perspective view showing a distal end portion of a probe according to a third embodiment of the present invention.

【図11】上記第3の実施形態のプローブの先端部を示
す底面図。
FIG. 11 is a bottom view showing the tip of the probe according to the third embodiment.

【図12】上記第3の実施形態のプローブの先端部を示
す縦断面図。
FIG. 12 is a longitudinal sectional view showing a distal end portion of the probe according to the third embodiment.

【図13】上記第3の実施形態のプローブの先端部を示
す横断面図。
FIG. 13 is a cross-sectional view showing a distal end portion of the probe according to the third embodiment.

【図14】上記第3の実施形態のプローブの先端部を心
筋に接触させた状態を示す断面図。
FIG. 14 is a cross-sectional view showing a state where the distal end of the probe according to the third embodiment is brought into contact with the myocardium.

【符号の説明】[Explanation of symbols]

1…制御装置 2…照射手段(光源) 3…参照光受光手段 4…受光手段(検出手段) 5…制御手段 10…代謝情報測定用プローブ 11…照射用ファイバ(照射光導光手段) 15…受光用ファイバ(散乱光導光手段) 18…先端部 19,30…保持手段 25…照射端面 26…受光端面 35…遮光手段 DESCRIPTION OF SYMBOLS 1 ... Control apparatus 2 ... Irradiation means (light source) 3 ... Reference light receiving means 4 ... Light receiving means (detection means) 5 ... Control means 10 ... Metabolic information measurement probe 11 ... Irradiation fiber (irradiation light guide means) 15 ... Light reception Fiber (scattered light guiding means) 18 ... Tip 19, 30 ... Holding means 25 ... Irradiation end face 26 ... Light receiving end face 35 ... Light shielding means

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 光源から発せられる近赤外光を当該プロ
ーブの先端部に配設された照射端面から照射して測定対
象まで導く照射光導光手段と、 この照射光導光手段により照射されて上記測定対象の内
部を透過した散乱光を当該プローブの先端部に配設され
た受光端面から入射して検出手段まで導く散乱光導光手
段と、 上記照射光導光手段の照射端面および上記散乱光導光手
段の受光端面を上記測定対象に対して接触させる際に当
該プローブの先端部を保持するための保持手段と、 を具備したことを特徴とする代謝情報測定用プローブ。
1. An irradiation light guide means for irradiating near infrared light emitted from a light source from an irradiation end face provided at the tip of the probe to guide the light to a measurement object. Scattered light guiding means for guiding the scattered light transmitted through the inside of the measurement object from the light receiving end face provided at the tip of the probe to the detecting means, the irradiation end face of the irradiation light guiding means and the scattered light guiding means A metabolic information measurement probe, comprising: holding means for holding the tip of the probe when the light-receiving end surface is brought into contact with the measurement object.
【請求項2】 上記保持手段は、バンド状をなして構成
されていることを特徴とする請求項1に記載の代謝情報
測定用プローブ。
2. The metabolic information measurement probe according to claim 1, wherein the holding means is formed in a band shape.
【請求項3】 上記保持手段は、突起状をなして構成さ
れていることを特徴とする請求項1に記載の代謝情報測
定用プローブ。
3. The metabolic information measurement probe according to claim 1, wherein said holding means is formed in a projecting shape.
JP9044411A 1997-02-27 1997-02-27 Metabolic information measuring probe Withdrawn JPH10234737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9044411A JPH10234737A (en) 1997-02-27 1997-02-27 Metabolic information measuring probe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9044411A JPH10234737A (en) 1997-02-27 1997-02-27 Metabolic information measuring probe

Publications (1)

Publication Number Publication Date
JPH10234737A true JPH10234737A (en) 1998-09-08

Family

ID=12690776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9044411A Withdrawn JPH10234737A (en) 1997-02-27 1997-02-27 Metabolic information measuring probe

Country Status (1)

Country Link
JP (1) JPH10234737A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005204869A (en) * 2004-01-22 2005-08-04 Matsushita Electric Ind Co Ltd Gums observing apparatus
JP2009233404A (en) * 2009-07-21 2009-10-15 Panasonic Electric Works Co Ltd Non-invasive type quantifying instrument of biological component
JP2013031644A (en) * 2011-06-30 2013-02-14 Og Giken Co Ltd Finger-mounted electrode and electric stimulation device including the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005204869A (en) * 2004-01-22 2005-08-04 Matsushita Electric Ind Co Ltd Gums observing apparatus
JP2009233404A (en) * 2009-07-21 2009-10-15 Panasonic Electric Works Co Ltd Non-invasive type quantifying instrument of biological component
JP2013031644A (en) * 2011-06-30 2013-02-14 Og Giken Co Ltd Finger-mounted electrode and electric stimulation device including the same

Similar Documents

Publication Publication Date Title
CN108471950B (en) System, device and method for monitoring blood oxygen saturation of transcarotomy fetus
JP3875798B2 (en) Method of operating a bloodless measuring device for blood component concentration and bloodless measuring device
JP3625475B2 (en) Non-intrusive system for monitoring hematocrit values
US10912504B2 (en) Near-infrared spectroscopy and diffuse correlation spectroscopy device and methods
KR100490461B1 (en) Stethoscope
US7440788B2 (en) Oral health measurement clamping probe, system, and method
US8423112B2 (en) Medical sensor and technique for using the same
JP4097522B2 (en) Biological light measurement device
JP2007209782A (en) Signal processing method and device for signal-to-noise ratio improvement
JP2010540964A (en) Optical device components
US7149562B2 (en) Needle with fiberoptic capability
JP2007083028A (en) Noninvasive inspecting apparatus
JP4772408B2 (en) Optical biological information measurement system and coupling layer used for optical information measurement
US20110245687A1 (en) Optical detection method and device for optical detection of the condition of joints
US7486978B2 (en) Catheter head
JP2005013597A (en) Bioinformation measuring instrument and method for measuring bioinformation from subject
JPH07132120A (en) Nonaggressive measuring method and device of specimen concentration using discontinuous emission
JPH078473A (en) Measurement device
JPH10234737A (en) Metabolic information measuring probe
JPH11137538A (en) Blood component measuring device, and method
KR100300960B1 (en) Method and device for noninvasive determination of the concentrations of blood components
JP2008289808A (en) Sensing apparatus for biological surface tissue
JP3635331B2 (en) Substance measuring device
JP2006305120A (en) Optical bioinstrumentation device
JP2005312743A (en) Glucose concentration measuring apparatus

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20040511